Rapid Micro Biosystems (RPID) Net Income towards Common Stockholders (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$14.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 26.74% year-over-year to -$14.3 million; the trailing twelve-month figure through Mar 2026 stood at -$50.1 million (down 11.83% YoY), and the FY2025 full-year result was -$47.1 million, changed 0.5% from the prior year.
• Net Income towards Common Stockholders eased to -$14.3 million in Q1 2026, from -$12.5 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.4 million in Q4 2022.
• A 5-year average of -$13.0 million and a median of -$13.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 38.56% in 2022 and retreated 29.29% in 2025, its largest moves.
• Tracing RPID's Net Income towards Common Stockholders over 5 years: stood at -$16.4 million in 2022, then surged by 32.07% to -$11.2 million in 2023, then climbed by 13.48% to -$9.7 million in 2024, then fell by 29.29% to -$12.5 million in 2025, then fell by 14.23% to -$14.3 million in 2026.
• Business Quant data shows RPID's Net Income towards Common Stockholders at -$14.3 million in Q1 2026, -$12.5 million in Q4 2025, and -$11.5 million in Q3 2025.